NPORT-EX 1 c10929dreyfusinve-march20191.htm Untitled Document

STATEMENT OF INVESTMENTS
Dreyfus Investment Portfolios, MidCap Stock Portfolio

March 31, 2019 (Unaudited)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.6%

     

Automobiles & Components - 1.6%

     

Gentex

   

116,510

 

2,409,427

 

Banks - 7.3%

     

BancorpSouth Bank

   

26,300

a

742,186

 

Cathay General Bancorp

   

63,255

 

2,144,977

 

Comerica

   

24,300

 

1,781,676

 

Commerce Bancshares

   

5,199

a

301,854

 

East West Bancorp

   

17,095

 

820,047

 

Popular

   

35,340

 

1,842,274

 

Synovus Financial

   

54,850

 

1,884,646

 

TCF Financial

   

86,380

 

1,787,202

 
    

11,304,862

 

Capital Goods - 8.3%

     

Allison Transmission Holdings

   

25,740

 

1,156,241

 

Curtiss-Wright

   

16,680

 

1,890,511

 

EMCOR Group

   

32,000

 

2,338,560

 

ITT

   

13,310

 

771,980

 

Kennametal

   

55,180

 

2,027,865

 

MSC Industrial Direct, Cl. A

   

1,960

 

162,112

 

Oshkosh

   

2,300

 

172,799

 

Pentair

   

11,310

 

503,408

 

Spirit AeroSystems Holdings, Cl. A

   

8,615

 

788,531

 

Teledyne Technologies

   

9,040

b

2,142,570

 

Terex

   

28,460

a

914,420

 
    

12,868,997

 

Commercial & Professional Services - .4%

     

HNI

   

17,260

 

626,365

 

Consumer Durables & Apparel - 4.4%

     

Brunswick

   

14,250

 

717,203

 

Deckers Outdoor

   

18,440

b

2,710,496

 

NVR

   

560

b

1,549,520

 

Under Armour, Cl. A

   

44,100

b

932,274

 

Under Armour, Cl. C

   

48,890

a,b

922,554

 
    

6,832,047

 

Consumer Services - 2.6%

     

Brinker International

   

5,400

 

239,652

 

International Speedway, Cl. A

   

7,240

b

315,881

 

Weight Watchers International

   

62,390

a,b

1,257,159

 

Wendy's

   

125,860

a

2,251,635

 
    

4,064,327

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.6% (continued)

     

Diversified Financials - 2.8%

     

Evercore, Cl. A

   

4,280

 

389,480

 

Federated Investors, Cl. B

   

62,420

a

1,829,530

 

SEI Investments

   

38,440

b

2,008,490

 
    

4,227,500

 

Energy - 2.3%

     

HollyFrontier

   

32,520

 

1,602,260

 

PBF Energy, Cl. A

   

61,660

 

1,920,092

 
    

3,522,352

 

Food, Beverage & Tobacco - 1.4%

     

Ingredion

   

22,740

 

2,153,251

 

Health Care Equipment & Services - 3.1%

     

Amedisys

   

12,260

b

1,511,167

 

Haemonetics

   

24,300

b

2,125,764

 

Masimo

   

6,860

b

948,601

 

West Pharmaceutical Services

   

1,900

 

209,380

 
    

4,794,912

 

Household & Personal Products - .7%

     

Edgewell Personal Care

   

18,050

a,b

792,215

 

Energizer Holdings

   

2,700

a

121,311

 

Herbalife Nutrition

   

2,800

a,b

148,372

 
    

1,061,898

 

Insurance - 4.9%

     

Brown & Brown

   

78,020

 

2,302,370

 

Kemper

   

11,920

 

907,589

 

Primerica

   

22,375

 

2,733,106

 

Torchmark

   

20,500

 

1,679,975

 
    

7,623,040

 

Materials - 6.1%

     

Allegheny Technologies

   

81,610

a,b

2,086,768

 

CF Industries Holdings

   

11,780

 

481,566

 

Chemours

   

41,180

 

1,530,249

 

Domtar

   

43,530

 

2,161,264

 

Greif, Cl. A

   

17,960

 

740,850

 

Huntsman

   

14,790

 

332,627

 

Louisiana-Pacific

   

84,840

 

2,068,399

 
    

9,401,723

 

Media & Entertainment - 3.5%

     

AMC Networks, Cl. A

   

35,240

a,b

2,000,222

 

John Wiley & Sons, Cl. A

   

20,700

 

915,354

 

TEGNA

   

39,530

 

557,373

 

TripAdvisor

   

37,530

a,b

1,930,919

 
    

5,403,868

 

Pharmaceuticals Biotechnology & Life Sciences - 9.2%

     

Agilent Technologies

   

6,320

 

508,002

 


        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.6% (continued)

     

Pharmaceuticals Biotechnology & Life Sciences - 9.2% (continued)

     

Bio-Rad Laboratories

   

5,570

b

1,702,638

 

Charles River Laboratories International

   

20,550

b

2,984,887

 

Exelixis

   

118,180

b

2,812,684

 

Mallinckrodt

   

84,670

b

1,840,726

 

Mettler-Toledo International

   

760

b

549,480

 

United Therapeutics

   

5,665

b

664,901

 

Waters

   

3,660

b

921,259

 

Zoetis

   

22,670

 

2,282,189

 
    

14,266,766

 

Real Estate - 7.6%

     

CubeSmart

   

6,100

c

195,444

 

First Industrial Realty Trust

   

75,570

c

2,672,155

 

Highwoods Properties

   

24,600

c

1,150,788

 

Hospitality Properties Trust

   

16,075

c

422,933

 

Lamar Advertising, Cl. A

   

34,605

c

2,742,792

 

Medical Properties Trust

   

83,470

c

1,545,030

 

Piedmont Office Realty Trust, Cl. A

   

17,880

c

372,798

 

Tanger Factory Outlet Centers

   

7,680

a,c

161,126

 

Weingarten Realty Investors

   

85,650

c

2,515,540

 
    

11,778,606

 

Retailing - 4.8%

     

American Eagle Outfitters

   

100,260

a

2,222,764

 

Best Buy

   

6,880

 

488,893

 

Dick's Sporting Goods

   

63,300

a

2,330,073

 

Foot Locker

   

5,960

 

361,176

 

Murphy USA

   

14,110

b

1,208,098

 

Signet Jewelers

   

27,710

a

752,604

 
    

7,363,608

 

Semiconductors & Semiconductor Equipment - 1.0%

     

ON Semiconductor

   

15,630

b

321,509

 

Silicon Laboratories

   

9,000

b

727,740

 

Xilinx

   

3,150

 

399,389

 
    

1,448,638

 

Software & Services - 11.7%

     

Aspen Technology

   

5,060

b

527,556

 

Broadridge Financial Solutions

   

11,870

 

1,230,800

 

CDK Global

   

43,630

 

2,566,317

 

Citrix Systems

   

5,620

 

560,089

 

CoreLogic

   

34,210

b

1,274,665

 

Fair Isaac

   

6,470

b

1,757,446

 

j2 Global

   

29,800

a

2,580,680

 

Manhattan Associates

   

47,470

a,b

2,616,072

 

MAXIMUS

   

34,500

 

2,448,810

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.6% (continued)

     

Software & Services - 11.7% (continued)

     

Science Applications International

   

21,460

 

1,651,347

 

WEX

   

4,610

b

885,074

 
    

18,098,856

 

Technology Hardware & Equipment - 6.1%

     

F5 Networks

   

6,750

b

1,059,278

 

Lumentum Holdings

   

43,610

b

2,465,709

 

Vishay Intertechnology

   

105,770

a

1,953,572

 

Xerox

   

22,630

 

723,707

 

Zebra Technologies, Cl. A

   

15,630

b

3,274,954

 
    

9,477,220

 

Transportation - 3.7%

     

Old Dominion Freight Line

   

18,100

 

2,613,459

 

United Continental Holdings

   

20,830

b

1,661,817

 

Werner Enterprises

   

40,800

a

1,393,320

 
    

5,668,596

 

Utilities - 6.1%

     

Black Hills

   

10,010

 

741,441

 

IDACORP

   

10,000

 

995,400

 

MDU Resources Group

   

62,860

 

1,623,674

 

New Jersey Resources

   

19,870

a

989,327

 

NRG Energy

   

48,750

 

2,070,900

 

OGE Energy

   

68,710

 

2,962,775

 
    

9,383,517

 

Total Common Stocks (cost $140,615,417)

   

153,780,376

 
  

1-Day
Yield (%)

     

Investment Companies - .4%

     

Registered Investment Companies - .4%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund
(cost $689,839)

 

2.46

 

689,839

d

689,839

 

Total Investments (cost $141,305,256)

 

100.0%

 

154,470,215

 

Liabilities, Less Cash and Receivables

 

.0%

 

(3,978)

 

Net Assets

 

100.0%

 

154,466,237

 

a Security, or portion thereof, on loan. At March 31, 2019, the value of the fund’s securities on loan was $24,165,960 and the value of the collateral held by the fund was $24,545,425, consisting of U.S. Government & Agency securities.

b Non-income producing security.

c Investment in real estate investment trust.

d Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s prospectus.


STATEMENT OF INVESTMENTS
Dreyfus Investment Portfolios, MidCap Stock Portfolio

March 31, 2019 (Unaudited)

The following is a summary of the inputs used as of March 31, 2019 in valuing the fund’s investments:

     
 

Level 1 - Unadjusted Quoted Prices

Level 2 - Other Significant Observable Inputs

Level 3 -Significant Unobservable Inputs

Total

Assets ($)

    

Investments in Securities:

  

Equity Securities—Common Stocks

153,780,376

-

-

153,780,376

Investment Companies

689,839

-

-

689,839

See Statement of Investments for additional detailed categorizations.


NOTES

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:

Investments in securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not


NOTES

traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the “Service”) approved by the Board Members (“Board”). These securities are generally categorized within Level 2 of the fair value hierarchy.

The Service’s procedures are reviewed by Dreyfus under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For restricted securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

Pursuant to a securities lending agreement with The Bank of New York Mellon, a subsidiary of BNY Mellon and an affiliate of Dreyfus,, the fund may lend securities to qualified institutions. It is the fund’s policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by Dreyfus, or U.S. Government and Agency securities. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a result of the lending transaction. Should a borrower fail to return the securities in a timely manner, The Bank of New York Mellon is required to replace the securities for the benefit of the fund or credit the fund with the


NOTES

market value of the unreturned securities and is subrogated to the fund’s rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At March 31, 2019, accumulated net unrealized appreciation on investments was $13,164,959, consisting of $21,339,151 gross unrealized appreciation and $8,174,192 gross unrealized depreciation.

At March 31, 2019, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.